Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients

Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin to Reduce the Cholesterol Levels in Outpatients in a Realistic Environment. A Retrospective Study

The aim of this study is to evaluate the effectiveness of Rosuvastatin versus Ezetimibe/Simvastatin in dyslipidemic patients treated for at least 8 weeks.

Inclusion Criteria:

• Dislipidemic population treated with rosuvastatin or ezetimibe/simvastatin for at least for 8 weeks
• Who have completed at least 80% of the treatment
• To have determinations at least of CT, TG C-LDL and CHDL before starting treatment and after 8 weeks of taking the medicine

Exclusion Criteria:

• Initiating different therapy lipid lowering to Rosuvastatin or Ezetimibe/Simvastatin